Hepatitis B Virus Clinical Trials

5 recruiting

Hepatitis B Virus Trials at a Glance

23 actively recruiting trials for hepatitis b virus are listed on ClinicalTrialsFinder across 6 cities in 13 countries. The largest study group is Phase 1 with 5 trials, with the heaviest enrollment activity in Guangzhou, Beijing, and Chengdu. Lead sponsors running hepatitis b virus studies include Nanfang Hospital, Southern Medical University, SCG Cell Therapy Pte. Ltd., and Bluejay Therapeutics Inc..

Browse hepatitis b virus trials by phase

Treatments under study

About Hepatitis B Virus Clinical Trials

Looking for clinical trials for Hepatitis B Virus? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hepatitis B Virus trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hepatitis B Virus clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 23 trials

Recruiting

The Role and Regulatory Mechanism of Germinal Center Immune Response in Hepatitis B Virus Infection

Hepatitis B Virus Infection
Nanfang Hospital, Southern Medical University280 enrolled1 locationNCT07240350
Recruiting
Phase 1

A Trial to Evaluate the Efficacy and Safety of WGc0201 in Patients With Chronic Hepatitis B Virus Infection

Chronic Hepatitis B Virus (Hbv)
Jiyan Liu9 enrolled1 locationNCT07051187
Recruiting
Phase 1

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection

Hepatitis B Virus Infection
GigaGen, Inc.48 enrolled16 locationsNCT07024641
Recruiting
Phase 1

A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis B

Chronic Hepatitis B Virus Infection
IntegerBio90 enrolled1 locationNCT07389044
Recruiting

Analysis of Methylomic Features and Prognostic Risk Prediction in Patients With Hepatitis B-related Acute-on-chronic Liver Failure

HBV-related Liver CirrhosisHBV Related Acute-on-chronic Liver FailureHBV (Hepatitis B Virus)
Qilu Hospital of Shandong University100 enrolled1 locationNCT07275554
Recruiting
Phase 4

Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV Donors

Hepatitis B Virus (HBV)Lung Transplant Recipient
University Health Network, Toronto20 enrolled1 locationNCT07189377
Recruiting

Immune Dynamics in the Natural History of Chronic HBV Infection

HBV InfectionHBV (Hepatitis B Virus)Chronic Hep B
Nanfang Hospital, Southern Medical University5,000 enrolled1 locationNCT07137247
Recruiting
Not Applicable

Gene Discovery in CHB Patients to Identify Unknown Pathways That Lead to B and NK Cell Deregulation

Chronic Hepatitis B Virus
University Hospital, Limoges140 enrolled3 locationsNCT06853886
Recruiting

Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study

Hepatitis B, Chronic (CHB)Hepatitis BHepatitis B Virus (HBV)
First Affiliated Hospital Xi'an Jiaotong University1,500 enrolled2 locationsNCT07079150
Recruiting
Phase 2

A Study to Evaluate the Efficacy and Safety of Combination Therapy of BRII-179, BRII-835 and PEG-IFNα in Participants With Chronic Hepatitis B Virus (HBV) Infection (ENHANCE)

Chronic Hepatitis B Virus (HBV) Infection
Brii Biosciences Limited250 enrolled14 locationsNCT06650852
Recruiting

New HBV Infection Biomarkers: Clinical Characterization and Impact on Management

Chronic Hepatitis B Virus (HBV) Infection
Assistance Publique - Hôpitaux de Paris900 enrolled1 locationNCT06906016
Recruiting

Non-Invasive Model for Fibrosis Regression in HBV Patients

Chronic Hepatitis B Virus (HBV) InfectionLiver Fibrosis
Beijing Friendship Hospital1,100 enrolled1 locationNCT06874127
Recruiting

A Non-interventional Registry for Patients with Hepatitis B Virus Infection

Hepatitis B Virus Infection
Hannover Medical School3,000 enrolled1 locationNCT05051098
Recruiting

Impact of Hepatitis B Virus on Inflammatory Bowel Disease

Inflammatory Bowel Disease (IBD)Hepatitis B Virus
Tanta University162 enrolled1 locationNCT06881238
Recruiting
Phase 1Phase 2

A Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma

Hepatitis B Virus Related Hepatocellular CarcinomaHepatocellular Carcinoma Recurrent
SCG Cell Therapy Pte. Ltd.46 enrolled6 locationsNCT05417932
Recruiting
Phase 1

A Study of SCG101 TCR-T Cell Therpay in the Treatment of Subjects With Hepatitis B Virus-Related

Hepatocellular CarcinomaHCCHepatitis B Virus Related Hepatocellular Carcinoma
SCG Cell Therapy Pte. Ltd.38 enrolled7 locationsNCT06617000
Recruiting
Not Applicable

Nucleoside (Acid) Analogues Treatment in Patients With Normal ALT and Positive HBVDNA.

Hepatitis B Virus
Third Affiliated Hospital, Sun Yat-Sen University200 enrolled1 locationNCT04231565
Recruiting

Hepatitis B Vaccination After Neonatal Surgery

Blood Transfusion ComplicationHepatitis B Virus InfectionVaccination Reaction+2 more
Children's Hospital of Chongqing Medical University180 enrolled1 locationNCT06023056
Recruiting
Phase 2

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of BJT-778 in Subjects with Chronic HBV Infection (CHB) and Chronic HDV Infection (CHD).

Chronic Hepatitis D Virus (HDV) InfectionChronic Hepatitis B Virus (HBV) Infection
Bluejay Therapeutics Inc.72 enrolled9 locationsACTRN12623000105640
Recruiting

Treatment and Prognosis of Patients With Chronic HBV Infection

Hepatitis B Virus Infection
Xiangya Hospital of Central South University500 enrolled1 locationNCT05392387